Zika Virus Vaccine Candidate TAK-426 Safe, Immunogenic, Well-Tolerated Among Both Flavivirus-Naive And Flavivirus-Primed Populations, Trial Shows

Infectious Disease Advisor (1/17, Barowski) reports, “Zika virus vaccine candidate TAK-426 is safe, immunogenic, and well-tolerated among both flavivirus-naive and flavivirus-primed populations,” according to a “randomized, observer-blinded, placebo-contr...